Neuburgh Advisers’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$30M Sell
141,760
-896
-0.6% -$187K 0.93% 29
2019
Q2
$27.7M Buy
142,656
+11,504
+9% +$2.12M 0.89% 28
2019
Q1
$21.6M Buy
131,152
+6,352
+5% +$1.12M 0.73% 34
2018
Q4
$23.5M Sell
124,800
-6,720
-5% -$1.24M 0.92% 30
2018
Q3
$22.4M Buy
131,520
+3,088
+2% +$520K 0.72% 36
2018
Q2
$21.1M Buy
128,432
+1,328
+1% +$217K 0.7% 37
2018
Q1
$20.6M Sell
127,104
-10,896
-8% -$1.73M 0.72% 39
2017
Q4
$20.2M Sell
138,000
-8,480
-6% -$1.21M 0.72% 36
2017
Q3
$19.9M Sell
146,480
-6,352
-4% -$802K 0.74% 38
2017
Q2
$19.1M Sell
152,832
-4,864
-3% -$582K 0.73% 38
2017
Q1
$18.7M Sell
157,696
-7,360
-4% -$885K 0.74% 35
2016
Q4
$19M Buy
+165,056
New +$18.4M 0.86% 31

Other funds holding CME

Neuburgh Advisers's CME Position: Q3 2019 in Review

Neuburgh Advisers reduced its CME Group (CME) stake by 0.63% in Q3 2019, selling an estimated $187K and leaving 141,760 shares worth $30M. The position accounts for 0.93% of the portfolio, ranked #29.

Neuburgh Advisers first reported a position in CME in Q4 2016 and has held it in 12 quarters since. 991 funds tracked by Wall St. Rank hold CME as of Q3 2019.

  • Neuburgh Advisers held 141,760 shares of CME Group worth $30M as of Q3 2019.
  • Neuburgh Advisers sold 896 CME Group shares in Q3 2019, an estimated $187K.
  • CME Group made up 0.93% of Neuburgh Advisers's portfolio in Q3 2019, its #29 holding.
  • Neuburgh Advisers first reported a position in CME Group in Q4 2016 and has held it in 12 quarters since.
  • 991 funds tracked by Wall St. Rank held CME Group as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.